COVID-19 Temporary Provisions

[Pages:20]COVID-19 Temporary Provisions

Date guide

Information reflects provisions effective as of Oct. 18, 2022. State variations and requirements may apply during this time. As needed, please refer to the Appendix for information on temporary provisions and suspensions that were implemented but are no longer in effect.

? 2022 United HealthCare Services, Inc. All Rights Reserved.

Summary of COVID-19 dates by program

? The following document is intended to be a quick reference guide for the beginning and end dates of temporary program, process or procedure changes that UnitedHealthcare has implemented as a result of COVID-19. Full details of these changes can be found at COVID19.

Please note: Where outlined, changes apply to Individual Exchange, Individual and fully insured Group Market health plans. Implementation for self-funded customers may vary.

? Medicaid state-specific rules and other state requirements may apply. For Medicaid and other state-specific requirements, please refer to your statespecific website or your state's UnitedHealthcare Community Plan website, if applicable. For more details, go to covid19.

? Medical management requirements may also apply, according to the member's benefit plan

2

? 2022 United HealthCare Services, Inc. All Rights Reserved.

Table of contents

Current temporary provisions ? Cost share waivers ? Testing ? Cost share waivers ? Treatment ? Telehealth cost share ? COVID-19 ? Telehealth expansion ? Timely filing ? Referrals and prior authorizations Expired temporary provisions ? Expired provisions ? Resources

3

Current cost share waivers ? Testing

(copays, coinsurance and deductibles)

Program or benefit scenario

COVID-19 diagnostic testing (physician ordered)

Medicare Advantage

Medicaid

Individual and Group Market health plans

Additional details

From Feb. 4, 2020, through the national public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share (copay, coinsurance and deductible) for innetwork and out-of-network tests.

State variations and requirements may apply during this time. Please refer to your state's COVID-19-specific website for more information.

From Feb. 4, 2020, through the national public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share (copay, coinsurance and deductible) for in-network and out-of-network tests.

? UnitedHealthcare will cover medically appropriate COVID-19 testing during the national public health emergency period (currently scheduled to end Jan. 10, 2023), at no cost share, when ordered or reviewed by a physician or appropriately licensed health care professional to either 1) diagnose if the virus is present due to symptoms or potential exposure, or 2) help in the treatment of the virus for a person..

? UnitedHealthcare health plans does not cover COVID-19 surveillance testing, which is testing used for public health or social purposes such as employment (return to workplace), education, travel, or entertainment. These tests are only covered when required by applicable law and adjudicated in accordance with member's benefit plan. o Exception for Administrative Services Only (ASO) plans: Effective Jan. 1, 2022, ASO plans may elect to cover surveillance testing claims administered by a health care provider under the medical benefit plan. Members are responsible for checking with their employer to see if they have elected to cover surveillance testing in 2022.

Over-the-counter (OTC) COVID-19 tests (physician ordered)

From Feb. 4, 2020, through the national State variations and

From Feb. 4, 2020, through the national ?

public health emergency period, currently requirements may apply public health emergency period, currently

scheduled to end Jan. 10, 2023,

during this time. Please scheduled to end Jan. 10, 2023,

UnitedHealthcare is waiving cost share

refer to your state's

UnitedHealthcare is waiving cost share

(copay, coinsurance and deductible) for in- COVID-19-specific

(copay, coinsurance and deductible) for

network and out-of-network tests when

website for more

in-network and out-of-network tests when ?

medically appropriate as ordered or

information.

medically appropriate as ordered or

reviewed by a physician or appropriately

reviewed by a physician or appropriately

licensed health care professional.

licensed health care professional.

Members will be responsible for the cost of OTC tests and may use their health savings account (HSA), flexible spending account (FSA) or health reimbursement account (HRA)

If you provide a prescription for an over-the-counter COVID19 test as part of clinical care, the member may submit a claim for reimbursement with both the prescription and detailed receipt to UnitedHealthcare

4

Current cost share waivers ? Testing (cont.)

(copays, coinsurance and deductibles)

Program or benefit scenario

Over-the-counter (OTC) COVID-19 tests without a prescription

Medicare Advantage

Medicaid

Individual and Group Market health plans

Additional details

Beginning April 4, 2022, all Medicare beneficiaries In accordance with the

Beginning Jan. 15, 2022, UnitedHealthcare ? Members can be reimbursed for up to 8 FDA-

with Part B coverage are eligible to get 8 free

American Rescue Plan, State will cover the cost of FDA-authorized or

authorized or approved OTC at-home diagnostic

FDA-authorized or approved over-the-counter

Medicaid and CHIP programs approved over-the-counter (OTC) at-home tests per covered member every calendar month

(OTC) at-home COVID-19 diagnostic tests every are required to cover FDA- COVID-19 diagnostic tests purchased on

at no cost to the member (no cost-sharing,

calendar month. This includes members enrolled in authorized at-home COVID- or after Jan. 15, 2022. This aligns with the

copay, coinsurance or deductible).

UnitedHealthcare's Medicare Advantage, Medicare 19 tests. People with

guidance released on Jan. 10, 2022, by

o The FDA website lists tests that fit these

Supplement and Medicare Prescription Drug plans. Medicaid or CHIP coverage the Departments of Labor, Treasury and

criteria

should contact their state

Health and Human Services (Tri-Agencies) o The limit of 8 tests per member every

The initiative runs from April 4, 2022 through the

Medicaid or CHIP agency for to support the Biden Administration's

calendar month does not apply to Standard

end of the national public health emergency period, information regarding the

directive on OTC at-home testing.

PCR tests administered by a doctor and

currently scheduled to end Jan. 10, 2023.

specifics of coverage for at-

processed by a lab.

home COVID-19 tests, as

UnitedHealthcare will not require a prior

o Members do not need a prescription to

For members enrolled in a Medicare Advantage

coverage rules may vary by authorization, to be reimbursed for the

request the OTC tests

plan, the tests covered under this initiative will be state.

OTC at-home tests.

? To qualify for coverage, members must

covered outside of the existing plan's coverage, and

purchase the OTC tests on or after the following

in addition to any over-the-counter tests that may be

dates, based on the type of health plan the

covered under the plan as a supplemental benefit.

member has. Tests purchased prior to that date

are not eligible for reimbursement:

Free COVID-19 tests for Medicare beneficiaries are

o Medicare: April 4, 2022

available at participating pharmacies, including

o Individual and Group Market: Jan. 15, 2022

CVS, Costco, Walgreens and Walmart.

o Medicaid: Varies by state

? Participating pharmacies can provide the tests

and bill Medicare on the member's behalf.

? Members are encouraged to bring their red,

white and blue Medicare card ? which is different

than the plan ID card ? to get the free tests.

However, the pharmacy may be able to bill

Medicare without the card.

5

Current cost share waivers ? Testing (cont.)

(copays, coinsurance and deductibles)

Program or benefit scenario

COVID-19 antibody testing

Medicare Advantage

From April 10, 2020, through the national public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share (copay, coinsurance and deductible) for innetwork and out-of-network tests.

COVID-19 testingrelated services

From Feb. 4, 2020, through the national public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share (copay, coinsurance and deductible) for innetwork and out-of-network testing-related services.

Medicaid

Individual and Group Market health plans

Additional details

State variations and requirements may apply during this time. Please refer to your state's COVID-19specific website for more information.

From April 10, 2020, through the

?

national public health emergency

period, currently scheduled to end Jan.

10, 2023, UnitedHealthcare is waiving

cost share for in-network and out-of-

network tests.

COVID-19 antibody testing must be an FDA-authorized test ordered by a physician or appropriately licensed health care professional, consistent with Centers for Medicare & Medicaid Services (CMS) requirements

State variations and requirements may apply during this time. Please refer to your state's COVID-19specific website for more information.

From Feb. 4, 2020, through the national ? public health emergency period, currently scheduled to end Jan. 10, 2023, UnitedHealthcare is waiving cost share for in-network and out-of-network testing-related services.

Services can be in person or via telehealth

6

Current cost share waivers ? Treatment

(copays, coinsurance and deductibles)

Program or benefit scenario

Medicare Advantage

COVID-19 treatment

As of April 1, 2021, no cost share waivers are in effect. Coverage and cost share (copay, coinsurance and deductible), including out-of-network costs, are adjudicated in accordance with the member's health plan. This includes telehealth, inpatient and outpatient COVID-19 treatment for both in-network and out-of-network services.

COVID-19 antiviral treatment

For Medicare health plans, administration claims for FDA-authorized or approved COVID-19 antiviral treatments for Medicare beneficiaries will be reimbursed with no cost share (copayment, coinsurance or deductible) through the national public health emergency, currently scheduled to end Jan. 10, 2023.

Medicaid

State variations and requirements may apply during this time. Please refer to your state's COVID-19-specific website for more information.

State variations and requirements may apply during this time. Please refer to your state's COVID-19-specific website for more information.

Reimbursement and cost share waivers are limited to antiviral treatments that are FDA-authorized or approved at the time of treatment.

Individual and Group Market fully insured health plans

No cost share waivers are currently in effect. Coverage and cost share (copay, coinsurance and deductible), including out-of-network costs, are adjudicated in accordance with the member's health plan.

Additional details

No cost share waivers are currently in effect. For medical health plans, coverage and cost share for both in-network and out-of-network treatment are adjudicated in accordance with the member's health plan.

As of April 4, 2022, there are 3 antiviral treatment options available:

Infusion ? Veklury (Remdesiver)

Oral ? Paxlovid (nirmatrelvir + ritonavir, co-

packaged) ? Lagevrio (molnupiravir)

Please review the COVID-19 Billing Guide and our website for additional antiviral treatment information.

State variations and requirements may apply during this time. Changes apply to Individual and fully insured Group Market health plans. Implementation for self-funded customers may vary. Medicaid state-specific rules and other state requirements may apply. For Medicaid and other state-specific requirements, please refer to your state-specific website or your state's UnitedHealthcare Community Plan website, if applicable. See covid19 for more 7 details. Dates are subject to change, based on the national public health emergency provisions.

Current cost share waivers ? Treatment

(copays, coinsurance and deductibles)

Program or benefit scenario

Monoclonal antibody treatment

Medicare Advantage

Medicaid

Individual and Group Market fully insured health plans

Additional details

For Medicare health plans, administration claims for FDAauthorized or approved COVID19 monoclonal antibody treatments for Medicare beneficiaries will be reimbursed with no cost share (copayment, coinsurance or deductible) through the national public health emergency.

Reimbursement and cost share waivers are limited to monoclonal antibody treatments that are FDA-authorized or approved at the time of treatment.

State variations and requirements may apply during this time. Please refer to your state's COVID-19-specific website for more information.

For Individual Exchange, Individual and Group Market health plans, the investigational monoclonal antibody treatment will be considered a covered benefit during the national public health emergency period, currently scheduled to end Jan. 10, 2023. Patients should meet the emergency use authorization (EUA) criteria for FDA-authorized or approved monoclonal antibody treatment in an outpatient setting.

As of April 1, 2021, no cost share waivers are in effect for the administration (intravenous infusion) of monoclonal antibodies. Coverage and cost share for both in-network and out-of-network treatment are adjudicated in accordance with the member's health plan.

As of April 5, 2022, there are 2 monoclonal antibody treatment options available: ? Bebtelovimab ? Evusheld (pre-exposure prophylaxis use only)

Please review the COVID-19 Billing Guide and our website for monoclonal antibody treatment information.

State variations and requirements may apply during this time. Changes apply to Individual and fully insured Group Market health plans. Implementation for self-funded customers may vary. Medicaid state-specific rules and other state requirements may apply. For Medicaid and other state-specific requirements, please refer to your state-specific website or your state's UnitedHealthcare Community Plan website, if applicable. See covid19 for more 8 details. Dates are subject to change, based on the national public health emergency provisions.

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download